Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?

BACKGROUND: There is a large lack of evidence for optimal treatment in oligometastatic head and neck cancer and it is especially unclear which patients benefit from radical local treatment of all tumour sites. METHODS: 40 patients with newly diagnosed oligometastatic head and neck cancer received ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Weissmann, Thomas, Höfler, Daniel, Hecht, Markus, Semrau, Sabine, Haderlein, Marlen, Filimonova, Irina, Frey, Benjamin, Bert, Christoph, Lettmaier, Sebastian, Mantsopoulos, Konstantinos, Iro, Heinrich, Fietkau, Rainer, Putz, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011153/
https://www.ncbi.nlm.nih.gov/pubmed/33789725
http://dx.doi.org/10.1186/s13014-021-01790-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011153/
https://www.ncbi.nlm.nih.gov/pubmed/33789725
http://dx.doi.org/10.1186/s13014-021-01790-w

Ejemplares similares